A systematic review of lung clearance index in non-cystic fibrosis, non-primary ciliary dyskinesia bronchiectasis.
A systematic review of lung clearance index in non-cystic fibrosis, non-primary ciliary dyskinesia bronchiectasis.
复制标题
非囊性纤维化、非原发性纤毛运动障碍、支气管扩张症肺清除指数的系统评价。
DOI:
10.1016/j.rmed.2022.106937
复制
发表时间:
2022
影响因子:
4.3
通讯作者:
Hine C
中科院分区:
文献类型:
--
作者:
Hine C
BackgroundNon cystic fibrosis, non primary ciliary dyskinesia bronchiectasis (nCFnPCD-BE) results in significant morbidity with few evidence-based treatments.Objectiveassessments are required to assess severity and evaluate treatment. Lung clearance index (LCI) measures ventilation inhomogeneity and is a sensitive test of disease in CF; its use in nCFnPCD-BE is unclear.MethodsA systematic review of LCI in nCFnPCD-BE was performed using standard methodology (protocol registered on PROSPERO, University of York).ResultsOf 276 records identified, 12 articles, describing 519 adult and paediatric patients in cross-sectional studies were included, addressing several domains.1: What is the utility of LCI in detecting disease and severity?LCI detected disease in adults, differentiating bronchiectasis from controls (AUC 0.90 to 0.96) and mild from moderate/severe bronchiectasis on CT (AUC 0.73).2: Does LCI correlate with spirometry and imaging?LCI correlated with spirometry in adult (r = −0.37 to −0.61) and paediatric (r = −0.6) groups, signs of bronchiectasis on CT, and CT scoring systems (modified Reiff).3: Does LCI relate to subjective scores of severity?In adults, LCI correlated with St. George's Respiratory Questionnaire (r = 0.18) and Bronchiectasis Severity Index (r = 0.45).4: Does LCI identify response to intervention?LCI did not change in studies examining LCI pre-post intervention (adults treated for exacerbation and undergoing physiotherapy).Overall study quality was variable.ConclusionContrary to data in CF, the review did not identify good quality studies defining the role of LCI in children with bronchiectasis. In adults, LCI was a sensitive measure of disease severity and correlated with clinical assessment tools.
登录
查看更多内容
DOI:
--
发表时间:
2013
期刊:
影响因子:
--
作者:
E. Hatziagorou;Vasiliki Avramidou;F. Kirvassilis;Kalliopi Kontouli;V. Georgopoulou;J. Tsanakas
通讯作者:
J. Tsanakas
DOI:
--
发表时间:
2015
期刊:
影响因子:
--
作者:
E. Hatziagorou;Petrina Vantsi;Vasiliki Avramidou;A. Kampouras;Fotios Kirvassilis;V. Georgopoulou;Maria Karailidou;J. Tsanakas
通讯作者:
J. Tsanakas
DOI:
--
发表时间:
2012
期刊:
影响因子:
--
作者:
E. Hatziagorou;Vasiliki Avramidou;F. Kirvassilis;Kalliopi Kontouli;S. Nikopoulos;J. Tsanakas
通讯作者:
J. Tsanakas
影响因子:
3.7
作者:
Ouzzani M;Hammady H;Fedorowicz Z;Elmagarmid A
通讯作者:
Elmagarmid A
影响因子:
6.9
作者:
K. O'Neill;G. Einarsson;S. Rowan;L. McIlreavey;A. J. Lee;J. Lawson;T. Lynch;A. Horsley;J. Bradley;J. Elborn;M. Tunney
通讯作者:
M. Tunney